Epiminder Ltd (EPI) fair value: what the stock is really worth
As of Oct 12, 2026: fair value of Epiminder Ltd A$0.27, price A$0.29, upside -4.6%, quality 31 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity.
Show more
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder app that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder cloud for processing; and Minder cloud, a secure, online portal which allows healthcare professionals to download patient data. Epi-Minder Pty Ltd was incorporated in 2017 and is based in Melbourne, Australia.
Stock analysis
Epiminder Ltd (EPI) currently trades at A$0.2850, while our model-based Fair Value estimate is A$0.2720, so the stock looks roughly fairly valued today (gap 4.8%).
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the evidence level at low.
Scenario range: A$0.1785 (bear) to A$0.3315 (bull), the price of A$0.2850 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 31/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Epiminder Ltd reported revenue of A$445K in FY2025 versus A$5.5M in FY2023, a compound −71.5%/yr. Reported net income was −A$42.7M in FY2026.
Key figures
Market cap A$61.8M (≈ $43.1M) · P/S ratio 26.4 · EPS (TTM) A$−0.2800 · Return on equity −302% · Return on assets (EBIT) −38.3% · Operating margin −1,105% · Revenue growth (YoY) +678%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at −5%, EPI screens richer than that median.
Fair Value models
Bear A$0.1785Fair Value A$0.2720Bull A$0.3315
Price A$0.2850 · Upside -4.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 329 stocks
Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score31 · Bottom 25%
Fair Value upside−4.6% · Above median
Profitability
Return on assets−38.9% · Bottom 25%
Growth and dividend
Revenue growth677.6% · Top 25%
Balance sheet
Debt / equity0.59× · Highest 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Epiminder Ltd Fair Value". https://www.fairvalue-calculator.com/stock/EPI
Frequently asked questions
Is Epiminder Ltd (EPI) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of A$0.2720 versus a price of A$0.2850, about −5% upside (fairly valued).
What is the fair value of EPI?
Our model-based fair value for Epiminder Ltd is A$0.2720 (as of Oct 3, 2026), built from audited fundamentals. The current price: A$0.2850.
What is the quality score of EPI?
Epiminder Ltd has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Epiminder Ltd (EPI)?
Our model-based price target is the fair value of A$0.2720 (as of Oct 3, 2026) from 1 valuation models. Cautious scenario A$0.1785, optimistic scenario A$0.3315. It is a calculation from audited fundamentals, not an analyst target.
What is the Epiminder Ltd stock forecast for 2026?
Our models put fair value at A$0.2720, about −5% upside versus a price of A$0.2850 (fairly valued). Cautious scenario A$0.1785, optimistic scenario A$0.3315. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Epiminder Ltd (EPI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Epiminder Ltd it is A$0.2720 per share (as of Oct 3, 2026), against a price of A$0.2850. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Epiminder Ltd stock overvalued or undervalued in 2026?
As of Oct 3, 2026, EPI trades above its calculated fair value: price A$0.2850, fair value A$0.2720, a gap of about −5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of EPI?
No. The price is what the market pays today (A$0.2850); the fair value is what the company's own numbers justify (A$0.2720). For Epiminder Ltd the two are A$0.0130 per share apart. That gap is exactly why we show both numbers side by side.
How much is Epiminder Ltd worth?
The market values Epiminder Ltd at about A$61.8M (market capitalisation, as of Oct 3, 2026). Per share that is A$0.2850; our models calculate a fair value of A$0.2720 per share.
What do the bullish and bearish scenarios say about EPI?
Our models span a range for Epiminder Ltd: cautious scenario A$0.1785, base A$0.2720, optimistic A$0.3315 per share (as of Oct 3, 2026, price A$0.2850). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Epiminder Ltd (EPI)?
Balance-sheet figures for Epiminder Ltd (as of Oct 3, 2026): return on equity −301.9%, debt of 0.59 per unit of equity. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
Which stocks are comparable to Epiminder Ltd?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Epiminder Ltd stock attractive at the current price?
The data as of Oct 3, 2026: price A$0.2850, calculated fair value A$0.2720 (−5%), Quality Score 31/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of EPI calculated?
We run Epiminder Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.2720, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Epiminder Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Epiminder Ltd (EPI)?
The closing price on Oct 12, 2026 was A$0.2850. Our model-based fair value is A$0.2720, about −5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Epiminder Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (A$0.1785 to A$0.3315) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Epiminder Ltd
How large is the market capitalisation of Epiminder Ltd (EPI)?
The market capitalisation of Epiminder Ltd is A$61.8M (≈ $43.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Epiminder Ltd (EPI)?
The price-to-sales ratio of Epiminder Ltd is 26.4 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Epiminder Ltd (EPI)?
Earnings per share at Epiminder Ltd are A$−0.2800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Epiminder Ltd (EPI)?
The return on equity (ROE) of Epiminder Ltd is −302% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Epiminder Ltd (EPI)?
On an EBIT basis the return on assets of Epiminder Ltd is −38.3% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Epiminder Ltd (EPI)?
The operating margin of Epiminder Ltd is −1,105% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Epiminder Ltd (EPI)?
Revenue at Epiminder Ltd is growing +678% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
Free · no account needed
Watch Epiminder Ltd in the live analysis
One click puts Epiminder Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
